Beth Israel Deaconess Medical — Boston, Massachusetts

Beth Israel Deaconess Medical is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical has participated in 3 clinical trials.

Therapeutic areas: Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Stroke.

Sponsors: Affimed GmbH, Columbia University, Cephalon.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical?

Beth Israel Deaconess Medical has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical conducted?

Beth Israel Deaconess Medical has 3 clinical trials on record. Their work covers Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Stroke.

Is Beth Israel Deaconess Medical accredited by Crixeo Health?

Beth Israel Deaconess Medical has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.